NITI Aayog explores policies to boost India's medical and dental device
Benchmarks Nifty23,146.15148.81FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.69 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.78 % Invest NowEnter search…

NITI Aayog is exploring policy measures to improve the manufacturing capabilities of medical and dental devices in India. The meeting included domestic manufacturers, government officials, and experts from IIT Delhi and IIT Mumbai. Key challenges such as regulatory hurdles and cost disadvantages faced by Indian manufacturers were discussed extensively. The industry body AiMeD emphasized the need for simpler regulations and financial support for local manufacturers.
New Delhi: The NITI Aayog is exploring comprehensive policy interventions to boost domestic manufacturing of medical and dental devices in the country.With a focus on addressing regulatory hurdles, infrastructure gaps and cost disadvantages faced by Indian manufacturers, the government's public policy think tank held a meeting on Wednesday with domestic devices and dental manufacturers, government officials from the departments of pharmaceuticals, health, science and technology, and the Indian Council of Medical Research, as well as experts from IIT Delhi and IIT Mumbai. E-commerce platforms involved in the trade of dental devices and the Association of Indian Medical Device Industry (AiMeD) also participated in the meeting.
Also Read: India needs 2.6 billion sq ft of healthcare space by 2035, says CBRE
Chaired by NITI Aayog vice chairman Ashok Lahiri, the meeting focused on identifying key challenges in domestic manufacturing and exploring regulatory, infrastructural and fiscal interventions needed to strengthen India's medical and dental device industry.
The consultation also aimed to identify opportunities for collaboration between the government and industry, and to formulate recommendations aligned with the country's healthcare priorities.
Live Events
Also Read: Indian, German firms to collaborate on immunoglobulin products: Indian Embassy
In a presentation submitted to the Aayog, the AiMeD called for a dedicated law for medical devices, simpler regulatory approvals and financial support to help domestic manufacturers compete with imported products.
The industry body said Indian manufacturers face a 10-15% cost disadvantage due to high capital and energy costs, logistics expenses, limited access to risk capital and inadequate testing and research infrastructure.
It also flagged the increasing regulatory burden, noting that setting up a manufacturing facility, which previously took about 18 months, can now take nearly four years because of multiple approvals, overlapping authorities and changing requirements.
Add as a Reliable and Trusted News Source Add Now!
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onNITI Aayogmedical device manufacturingdental device productiondomestic manufacturingmedical devices policyIndian Council of Medical Researchregulatory hurdlesAssociation of Indian Medical Device Industry (AiMeD)manufacturing costshealthcare priorities
(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)
...moreless(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onNITI Aayogmedical device manufacturingdental device productiondomestic manufacturingmedical devices policyIndian Council of Medical Researchregulatory hurdlesAssociation of Indian Medical Device Industry (AiMeD)manufacturing costshealthcare priorities
(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)
...morelessContinue reading with one of these options:Limited AccessFreeLogin to get access to some exclusive stories& personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions &
in-depth stock reportsSubscribe NowET
Unlock Access to All Exclusives with ETPrime FREE TRIAL
15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers
Trial offer expiring in00 : 05 : 00
I'd rather pay ₹2599 nowUh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Prime Account Detected!
It seems like you're already an ETPrime member with
Login using your ET Prime credentials to enjoy all member benefits
Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.
Unlock ETPrime's Exclusive Stories Today!
Big Price Drop! Flat 40% Off
Student Only OfferAlready a Member? Sign In nowAlready a Member? Sign In nowAlready a Member? Sign In nowOffer Exclusively For You
Save up to Rs. 700/-
ON ET PRIME MEMBERSHIP
Avail OfferOffer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail OfferOffer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail OfferOffer Exclusively For You
Get Flat 40% Off
Then ₹ 1749 for 1 year
Avail OfferOffer Exclusively For You
ET Prime at ₹ 49 for 1 month
Then ₹ 1749 for 1 year
Avail OfferSpecial Offer
Get flat 40% off on ETPrime
Avail OfferAvail OfferClaim NowAlready a Member? Sign In nowNeed Assistance?
Connect with an ETPrime expert for personalized support and guidance
+91 9484700004'; }); } if(listing) { var h3 = "You tried reading " + listArr.length + " locked stories in the past " + threshold + " days.", h4 = "Become an ET Prime member and don't miss out on these exclusive stories."; var html = '' + h3 + '
' + h4 + '
- ' + listing + '
What’s Included with
ETPrime Membership
1Exclusive Insights That Matter
Uncover the truth with our investigative stories
Make strategic moves using the real-world case studies
Read industry-specific stories to identify emerging trends
Spot opportunities with in-depth insights that matter
Trump temper on H-1B visas is forcing Indians to do these things to stay put in US
What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.
Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?
The problem with lab grown diamonds
Why a falling rupee is a better option for the economy
A list of top 20 momentum stocks that have delivered massive returns in one year
2Invest Wisely With Smart Market Tools & Investment Ideas
Alpha Trade
Get daily trade ideas from SEBI-registered research analysts.
Investment Ideas
Grow your wealth with stock ideas & sectoral trends.
Stock Reports Plus
All-in-one stock research with Stock Score, peer comparison & key signals.
BigBull Portfolio
Get to know where the market bulls are investing to identify the right stocks.
Stock Analyzer
Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks.
Market Mood
Analyze the market sentiments & identify the trend reversal for strategic decisions.
Stock Talk Live at 9 AM Daily
Ask your stock queries & get assured replies by ET appointed, SEBI registered experts.
3Stay informed anytime, anywhere with ET ePaper
ePaper - Print View
Read the PDF version of ET newspaper. Download & access it offline anytime.
ePaper - Digital View
Read your daily newspaper in Digital View & get it delivered to your inbox everyday.
Wealth Edition
Manage your money efficiently with this weekly money management guide.
TOI ePaper
Read the PDF version of TOI newspaper. Download & access it offline anytime.
Deep Explainers
Explore the In-depth explanation of complex topics for everyday life decisions.
Health+ Stories
Get fitter with daily health insights committed to your well-being.
Personal Finance+ Stories
Manage your wealth better with in-depth insights & updates on finance.
5Enjoy Complimentary Subscriptions From Top Brands
Stream new documentaries from all across the world every day.
Stories you might be interested in
Figures reflect the source report and its stated period. This article is for information and is not investment advice.



